SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
________________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 or 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
December 1, 1997
CROWN LABORATORIES, INC.
----------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware
----------------------------------------------
(State or other jurisdiction of incorporation)
1-12848 75-2300995
---------------------- ---------------------------------
Commission File Number (IRS Employer Identification No.)
6780 Caballo Street, Las Vegas, NV 89119
-------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
(702) 696-9300
--------------------------------------------------
Registrant's telephone number, including area code
<PAGE>
Item 5. Other Events.
The Company has engaged an investment banker to raise
privately up to $16 million in cash from the offer and sale of
subordinated notes and/or convertible preferred stock. The
securities will not be registered under the Securities Act of
1933 and, subsequent to sale, may not be offered or sold absent
registration or an applicable exemption from the registration
requirements of the Securities Act and applicable state
securities laws.
The particular terms of such securities have not been set.
The time period of such offering is expected to be during the
next two fiscal quarters. The capital raised will be used for
general corporate purposes.
The above statement shall not constitute an offer to sell or
the solicitation of any offer to buy the securities. This
statement is filed in accordance with Securities Act Rule 135c.
2
<PAGE>
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned, thereto duly authorized.
CROWN LABORATORIES, INC.
By: /s/ Craig E. Nash
--------------------------
Name: Craig E. Nash
Title: Chairman of the
Board and Chief
Executive Officer
Dated: December 1, 1997
3
